Myosmine
CAS No. 532-12-7
Myosmine( —— )
Catalog No. M20968 CAS No. 532-12-7
Myosmine is a minor tobacco alkaloid that is structurally related to nicotine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | Get Quote |
|
| 200MG | 60 | Get Quote |
|
| 500MG | 107 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMyosmine
-
NoteResearch use only, not for human use.
-
Brief DescriptionMyosmine is a minor tobacco alkaloid that is structurally related to nicotine.
-
DescriptionMyosmine is a minor tobacco alkaloid that is structurally related to nicotine.
-
In VitroMyosmine is easily nitrosated, yielding 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) and the esophageal tobacco carcinogen N'-nitrosonornicotine.
-
In VivoMyosmine (0.001, 0.005, 0.5, and 50 micromol/kg; oral; in Wistar rats) causes a higher percentage of the radioactivity excreted in urine (86.2% and 88.9%) at the two lower doses (0.001 and 0.005 micromol/kg),as compared with the higher doses (0.5 and 50 micromol/kg), where only 77.8% and 75.4% of the dose is found in urine.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number532-12-7
-
Formula Weight146.19
-
Molecular FormulaC9H10N2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : ≥ 100 mg/mL (684.04 mM))
-
SMILESc1cncc(C2=NCCC2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
3-Epiursolic acid
3-Epiursolic acid may have antiinflammatory activity, it shows inhibition on Cathepsins L (catL), the IC50 value of 6.5 μM, cathepsins L (catL) and B play an important role in tumor progression and have been considered promising therapeutic targets in the development of novel anticancer agents.
-
Casegravol
Casegravol shows antiproliferative activity against human gastric adenocarcinoma (MK-1), human uterus carcinoma (HeLa), and murine melanoma (B16F10) cells.
-
Glycogen phosphoryla...
Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus.
Cart
sales@molnova.com